CNTB - Connect Biopharma Holdings Ltd - ADR
IEX Last Trade
1.55
0.270 17.419%
Share volume: 216,525
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.27
21.09%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
56.54%
1 Month
34.45%
3 Months
2.24%
6 Months
35.59%
1 Year
97.53%
2 Year
13.48%
Key data
Stock price
$1.55
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.53 - $2.84
52 WEEK CHANGE
$1.00
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: connectbiopharm.com
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: connectbiopharm.com
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
suzhou connect biopharmaceuticals, ltd. is a pharmaceuticals company based out of 10th floor, xiangtang development building, #3 chaoyang dong rd, taicang, china.
Recent news